Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Income Statement 
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

HCA Healthcare Inc., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Revenues 14,945 15,064 15,276 14,435 13,977 14,293 13,311 11,068 12,861 13,523 12,694 12,602 12,517 12,274 11,451 11,529 11,423 11,562 10,696 10,733 10,623
Supplies (2,321) (2,414) (2,463) (2,380) (2,224) (2,370) (2,128) (1,748) (2,123) (2,232) (2,090) (2,118) (2,041) (2,002) (1,890) (1,917) (1,915) (1,947) (1,777) (1,795) (1,797)
Gross profit 12,624 12,650 12,813 12,055 11,753 11,923 11,183 9,320 10,738 11,291 10,604 10,484 10,476 10,272 9,561 9,612 9,508 9,615 8,919 8,938 8,826
Salaries and benefits (6,939) (6,999) (7,094) (6,385) (6,301) (6,329) (6,097) (5,330) (6,118) (6,105) (5,971) (5,837) (5,647) (5,485) (5,377) (5,274) (5,289) (5,181) (5,081) (4,896) (4,901)
Other operating expenses (2,752) (2,537) (2,530) (2,473) (2,421) (2,482) (2,251) (2,147) (2,427) (2,468) (2,352) (2,362) (2,299) (2,283) (2,097) (2,118) (2,110) (2,081) (2,075) (1,965) (1,930)
Government stimulus income (reversal) (822) 822
Depreciation and amortization (732) (728) (716) (712) (697) (662) (694) (691) (674) (694) (647) (636) (619) (581) (582) (562) (553) (550) (539) (521) (521)
Gains (losses) on sales of facilities 10 563 1,047 8 2 (1) 14 (27) 7 1 18 (1) 8 6 9 405 (2) 7 2 1
Operating income 2,211 2,949 3,520 2,493 2,336 2,449 1,333 1,947 1,526 2,025 1,634 1,667 1,910 1,931 1,511 1,667 1,961 1,801 1,231 1,558 1,475
Equity in earnings of affiliates 11 35 35 22 21 6 40 1 7 20 4 8 11 4 9 7 9 9 13 13 10
Interest expense (408) (398) (398) (386) (384) (383) (385) (388) (428) (438) (448) (477) (461) (446) (442) (436) (431) (433) (427) (411) (419)
Losses on retirement of debt (12) (295) (211) (9) (39)
Income before income taxes 1,814 2,586 3,157 2,117 1,973 2,072 988 1,560 810 1,607 979 1,198 1,460 1,489 1,069 1,238 1,539 1,377 778 1,160 1,066
Provision for income taxes (349) (581) (685) (453) (393) (378) (209) (344) (112) (334) (215) (271) (279) (244) (173) (272) (257) (736) (248) (365) (289)
Net income 1,465 2,005 2,472 1,664 1,580 1,694 779 1,216 698 1,273 764 927 1,181 1,245 896 966 1,282 641 530 795 777
Net income attributable to noncontrolling interests (192) (191) (203) (214) (157) (268) (111) (137) (117) (202) (152) (144) (142) (181) (137) (146) (138) (167) (104) (138) (118)
Net income attributable to HCA Healthcare, Inc. 1,273 1,814 2,269 1,450 1,423 1,426 668 1,079 581 1,071 612 783 1,039 1,064 759 820 1,144 474 426 657 659

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).


The financial data exhibits several notable trends over the analyzed periods. Revenues generally demonstrate a steady upward trajectory from March 2017 through March 2022, with some fluctuations notably in 2020 likely influenced by external factors impacting the healthcare sector globally. The revenue growth trend is consistent, reflecting expansion or increased service demand.

Supply costs, expressed as negative values, increase modestly over time, aligning with revenue trends but showing some variability. A pronounced dip in supply costs occurs in the first half of 2020, which subsequently rises sharply toward the end of that year and beyond, possibly reflecting operational adjustments or supply chain volatility.

Gross profit follows the revenue pattern, increasing steadily except for a noticeable dip in mid-2020. This dip corresponds with the reduction in revenues and margins likely due to pandemic-related disruption. Recovery thereafter is strong, with gross profit surpassing previous peaks by the end of 2021 and into 2022.

Salaries and benefits costs consistently rise over the entire period, indicating either workforce expansion or wage increases. However, a reduction occurs in mid-2020 before resuming the increasing trend, which may relate to pandemic-induced labor adjustments. Other operating expenses also gradually increase but exhibit a significant decrease around mid-2020, again possibly pandemic-related, before climbing steadily afterward.

Government stimulus income appears only in the second quarter of 2020, reflecting external financial support during that period, which is reversed in the subsequent quarter, suggesting temporary impact without long-term effect on operating expenses.

Depreciation and amortization expenses steadily increase throughout the timeline, consistent with investment in fixed assets or acquisitions. Gains and losses on sales of facilities are sporadic with some significant positive spikes in early 2020 and late 2021, suggesting occasional asset disposals resulting in gains.

Operating income displays variability but generally trends upward, peaking in late 2021. There is a dip during 2020, coinciding with the global health crisis, but a strong recovery follows, supported by increased revenues and controlled operating costs.

Equity earnings from affiliates are relatively minor and fluctuate without a clear trend, indicating a limited but varying contribution to overall income.

Interest expense remains relatively stable, with a slight decline observed in 2020, which could indicate refinancing or debt management efforts. Losses on retirement of debt appear intermittently, with notable expenses in 2019 and 2020, aligning with potential debt restructuring activities.

Income before income taxes parallels operating income trends, showing a decline in 2020 with recovery in subsequent periods, peaking significantly in late 2021. Provision for income taxes varies substantially, with notable higher tax provisions in late 2017 and from late 2020 onward, impacting net income outcomes.

Net income attributable to the company exhibits a strong increase from 2017 through early 2020, a decline during the pandemic’s peak impact periods in 2020, and a robust rebound thereafter. The fluctuations align closely with operational income and tax trends, demonstrating resilience and recovery capability post-challenges.

Overall, the data indicate stable financial growth with temporary setbacks in 2020, consistent with external disruptions. Cost management, particularly in salaries, benefits, and other operating expenses, shows responsiveness to changing conditions. Revenue growth and operational profitability remain strong drivers of net income recovery in the final periods analyzed.